Stock listing

A419UB Stock Price, News, Filings & Events — Nektar Therapeutics

Selected listing: A419UB · LSX · EUR · DE

The selected listing A419UB:LSX represents Nektar Therapeutics, a biopharmaceutical company focused on discovering and developing innovative therapies for patients with serious diseases. The company is actively engaged in clinical trials and research to advance its pipeline of drug candidates. Recent news and filings highlight its ongoing efforts to address unmet medical needs in various therapeutic areas. Investors can stay updated on upcoming events and market developments that may impact the company's performance.

A419UB:LSXEURDEUpdated July 24, 2026
Nektar Therapeutics logo
Ticker
A419UB:LSX
Asset type
Stock
Market cap
$2.39B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LSX
Currency
EUR

Nektar Therapeutics A419UB:LSX stock context

The selected listing A419UB:LSX represents Nektar Therapeutics, a biopharmaceutical company focused on discovering and developing innovative therapies for patients with serious diseases. The company is actively engaged in clinical trials and research to advance its pipeline of drug candidates. Recent news and filings highlight its ongoing efforts to address unmet medical needs in various therapeutic areas. Investors can stay updated on upcoming events and market developments that may impact the company's performance.

Research Nektar Therapeutics

Alternate listings